ACM
XENE icon

ADAR1 Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History

ADAR1 Capital Management’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.3M Buy
228,899
+24,930
+12% +$1.15M 0.8% 30
2025
Q4 		$9.14M Buy
203,969
+14,871
+8% +$625K 0.68% 37
2025
Q3 		$7.59M Sell
189,098
-70,405
-27% -$2.48M 0.75% 38
2025
Q2 		$8.12M Buy
259,503
+131,955
+103% +$4.3M 1.32% 20
2025
Q1 		$4.28M Buy
127,548
+77,001
+152% +$2.92M 0.82% 33
2024
Q4 		$1.98M Buy
50,547
+22,644
+81% +$936K 0.41% 49
2024
Q3 		$1.1M Buy
27,903
+23,203
+494% +$936K 0.18% 66
2024
Q2 		$183K Buy
+4,700
New +$188K 0.04% 146

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return